Yahoo Web Search

Search results

  1. Jan 26, 2024 · SU2C Scientific Advisory Committee. Luis A. Diaz, Jr., M.D. Head, Division of Solid Tumor Oncology Memorial Sloan Kettering Cancer Center Member, Stand Up To Cancer Scientific Advisory Committee New York, NY. . is a physician-scientist who leads the Division of Soli. Tumor Oncology at Memorial Sloan Kettering Cancer Center. His team pioneered ...

  2. 2016. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. LA Diaz Jr, RT Williams, J Wu, I Kinde, JR Hecht, J Berlin, B Allen, I Bozic, ... Nature 486 (7404), 537-540.

  3. Luis Diaz, MD, is the Head of the Division of Solid Tumor Oncology at Memorial Sloan Kettering Cancer Center in New York. Dr. Diaz led the landmark study of PD-1 blockade in MSI CRC, the first successful trial of immunotherapy in CRC, which has led to pembrolizumab receiving FDA breakthrough designation in treatment-refractory colorectal cancer with mismatch repair deficiency.

  4. Jun 3, 2019 · Luis Diaz, MD; Elizabeth Platz, ScD, MPH; and Beverly Teicher, PhD, are profiled. On April 1, Luis A. Diaz, MD, became co–editor-in-chief of Cancer Discovery, joining Lewis Cantley, PhD. Diaz is the head of the Division of Solid Tumor Oncology at Memorial Sloan Kettering Cancer Center in New York, NY. He was previously an associate professor ...

  5. May 10, 2018 · As part of our coverage of the American Association for Cancer Research annual meeting, held April 14 –18 in Chicago, Ill., we spoke with Luis Diaz, MD, a medical oncologist who heads the division of solid tumor oncology at the Memorial Sloan Kettering Cancer Center in New York City. Dr. Diaz's research team is developing novel ways to use cancer genetics for better diagnosis and treatment ...

  6. People also ask

  7. Luis A. Diaz Jr., MD Email: ldiaz@mskcc.org. Phone: 1646-888-4204 Interests/specialties: Medical Oncology. Resources: Pubmed. Elected 2018 Memorial Sloan Kettering ...

  1. People also search for